Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People with a type of irregular heartbeat called atrial fibrillation (AF) — whether it comes and goes, has lasted a long time, or is ongoing — that is not caused by a heart valve problem, and who have a stroke risk score of 2 or higher on a standard medical scoring system called CHA2DS2-VASc
- People who are already scheduled for a planned procedure to close off a small pouch in the heart called the left atrial appendage (LAA), which is done to reduce stroke risk
- People whose heart anatomy is suited to receiving an approved medical device used for this type of closure procedure
- People who are willing to sign a written consent form agreeing to take part in the study
Who may not be able to join:
- People who are not willing to sign the consent form agreeing to participate in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lorenz Räber, Prof., Insel Gruppe AG, Inselspital, Universitätsklinik für Kardiologie
Phone: 31 632 09 29
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Safety Endpoint; Primary Efficacy Endpoint - Incidence of cardiovascular death, ischemic stroke and systemic embolism; Secondary Efficacy Endpoint - Incidence of technical success; Feasibility Endpoint - Total procedure time (min); Feasibility Endpoint - dose of contrast medium (ml); Feasibility Endpoint - dose of x-ray (cGy.cm2); Feasibility Endpoint - number of device implantation attempt during the procedure (number); Feasibility Endpoint - number of device change during the procedure (number); Net Clinical Benefit Endpoint; LAA patency; Device related thrombus
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.